The field of toxicology is changing fast and Kaptis is another Lhasa Limited solution that demonstrates how AI tools can simultaneously raise the quality of decisions whilst reducing time, cost, animals and the need for expertise when making decisions on chemical safety. Kaptis does this by making data, knowledge and the decision-making approaches of experts available to all. Thanks to the whole team for this latest release!
We are delighted to announce the launch of Kaptis 2. Our enhanced in silico solution is supporting organisations to more efficiently evaluate compound carcinogenic potential, whilst building more ethical and environmentally friendly assessments. Find out more about using Kaptis to bridge the gap between non-animal studies and confident safety assessments: https://buff.ly/4dAWBAP 📣 Adrian Fowkes, PhD, Director of Science at Lhasa shares his thoughts on the launch: “Increasingly, non-animal studies can provide sufficient evidence for safety assessments; however, risk assessors often face challenges." "Utilising an adverse outcome pathway framework, Kaptis contextualises evidence, enabling confident decisions to be made by both assessors and reviewers.” #carcinogenicity #ICHS1 #safetyassessment #drugdevelopment #NAMs